Evidence map›Paper›PMID 21133677›Full record

ArticleAssay and drug development technologies2011

Design of a flexible cell-based assay for the evaluation of heat shock protein 70 expression modulators.

James H Ahn, Wenjie Luo, Joungnam Kim, Anna Rodina, Cristina C Clement, Julia Aguirre, Weilin Sun, Yanlong Kang, Ronnie Maharaj, Kamalika Moulick and 4 more

Abstract read
In one paragraph

Article in Assay and drug development technologies, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

James H AhnDepartment of Medicine and Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York.
Wenjie Luo
Joungnam Kim
Anna Rodina
Cristina C Clement
Julia Aguirre
Weilin Sun
Yanlong Kang
Ronnie Maharaj
Kamalika Moulick
Danuta Zatorska
Malgorzata Kokoszka
Jeffrey L Brodsky
Gabriela Chiosis
Memorial Sloan Kettering Cancer Center · USRockefeller Foundation · USUniversity of Pittsburgh · US

Funding

Small molecule Hsp90 inhibitors in AD treatmentU01AG032969 · NIA · SLOAN-KETTERING INST CAN RESEARCH · PI CHIOSIS, GABRIELA · 2010 to 2014
$3.5M
Assays for rapid identification of Hsp70 modulatorsR01CA119001 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI CHIOSIS, GABRIELA · 2006 to 2008
$927k
The role of Hsp 90 in Alzheimer's DiseaseK01AG032364 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI LUO, WENJIE · 2010 to 2014
$647k
Hsp90 inhibitors as suppressors of protein misfolding toxicityR21AG028811 · NIA · SLOAN-KETTERING INST CAN RESEARCH · PI CHIOSIS, GABRIELA · 2007 to 2008
$406k
NCI NIH HHS 5 R01 CA119001-03NIA NIH HHS 1 U01AG032969-01A1NIA NIH HHS 5-R21AG028811-2NIA NIH HHS K01 AG032364-01A2
6 · The paper itself

Abstract

Heat shock protein 70 (Hsp70) is a chaperone protein that helps protect against cellular stress, a function that may be co-opted to fight human diseases. In particular, the upregulation of Hsp70 can suppress the neurotoxicity of misfolded proteins, suggesting possible therapeutic strategies in neurodegenerative diseases. Alternatively, in cancer cells where high levels of Hsp70 inhibit both intrinsic and extrinsic apoptotic pathways, a reduction in Hsp70 levels may induce apoptosis. To evaluate and identify, in a single assay format, small molecules that induce or inhibit endogenous Hsp70, we have designed and optimized a microtiter assay that relies on whole-cell immunodetection of Hsp70. The assay utilizes a minimal number of neuronal or cancer cells, yet is sufficiently sensitive and reproducible to permit quantitative determinations. We further validated the assay using a panel of Hsp70 modulators. In conclusion, we have developed an assay that is fast, robust, and cost efficient. As such, it can be implemented in most research laboratories. The assay should greatly improve the speed at which novel Hsp70 inducers and inhibitors of expression can be identified and evaluated.

Indexed as

Drug DesignBreast NeoplasmsCell Line, TumorGene Expression Regulation, EnzymologicHSP70 Heat-Shock ProteinsHumansImmunoassayNeuroblastomaNeuronsUp-RegulationHSP70 Heat-Shock Proteins

Identifiers

PMID21133677
PMCPMC3102259
OpenAlexW2095547754

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.